Department of Cancer Biostatistics, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina, USA.
Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia, USA.
Pharm Stat. 2021 May;20(3):563-572. doi: 10.1002/pst.2094. Epub 2021 Jan 22.
Response-adaptive (RA) allocation designs can skew the allocation of incoming subjects toward the better performing treatment group based on the previously accrued responses. While unstable estimators and increased variability can adversely affect adaptation in early trial stages, Bayesian methods can be implemented with decreasingly informative priors (DIP) to overcome these difficulties. DIPs have been previously used for binary outcomes to constrain adaptation early in the trial, yet gradually increase adaptation as subjects accrue. We extend the DIP approach to RA designs for continuous outcomes, primarily in the normal conjugate family by functionalizing the prior effective sample size to equal the unobserved sample size. We compare this effective sample size DIP approach to other DIP formulations. Further, we considered various allocation equations and assessed their behavior utilizing DIPs. Simulated clinical trials comparing the behavior of these approaches with traditional Frequentist and Bayesian RA as well as balanced designs show that the natural lead-in approaches maintain improved treatment with lower variability and greater power.
响应自适应 (RA) 分配设计可能会根据之前累积的反应,偏向表现较好的治疗组进行入组分配。虽然不稳定的估计量和增加的变异性可能会对早期试验阶段的适应性产生不利影响,但贝叶斯方法可以通过使用信息量逐渐减少的先验 (DIP) 来克服这些困难。DIP 先前已用于二分类结果,以在试验早期限制适应性,但随着受试者的累积,适应性逐渐增加。我们将 DIP 方法扩展到连续结果的 RA 设计中,主要是在正态共轭族中,通过将先验有效样本量函数化为未观察到的样本量。我们将这种有效样本量 DIP 方法与其他 DIP 公式进行了比较。此外,我们还考虑了各种分配方程,并利用 DIP 评估了它们的行为。模拟临床试验比较了这些方法与传统的 Frequentist 和 Bayesian RA 以及平衡设计的行为,结果表明自然先导方法在保持改善治疗效果的同时,降低了变异性,提高了功效。